logo
The Skrmetti Case Could End Gender-Affirming Care for Trans Youth. These Families Explain Why They Sought It

The Skrmetti Case Could End Gender-Affirming Care for Trans Youth. These Families Explain Why They Sought It

Yahooa day ago

ROBYN BECK/AFP via Getty Images | Liz Coulbourn
Content warning: This article includes descriptions of self-harm and suicide. Resources are listed at the bottom of the story.
Eleven days before the state of Missouri ended healthcare for young people with gender dysphoria, then-15-year-old Kai came out to her parents as transgender. Checking on her new daughter that night before bed, her mom Esther told Teen Vogue, was the first time she'd seen her child truly happy.
A highly significant Supreme Court decision is approaching, and the lives of trans teens and their families hang in the balance. United States vs Skrmetti will decide, once and for all, whether state bans on gender-affirming treatments are constitutional. If the court sides with Tennessee, its ban and other similar laws will remain in place. Nationally, access to gender affirming care has also been threatened by a presidential executive order and the Republican-dominated congress, but these efforts thus far have fallen short of a full ban.
At stake in Skrmetti, advocates say, is safety and stability for trans youth and their families. If the conservative-leaning court upholds state care bans, loving families fear the prospect that their children could be removed by state child protective services. (Due to the seriousness of these potential legal threats, this piece uses pseudonyms for trans youth and their families in states with bans.)
Why have some families decided to risk everything for these treatments? The answer, families say, is as simple as love. Those Teen Vogue spoke to describe how decisions to seek gender-affirming treatments sprang from the trust trans youth placed in their parents, and parents' drive to do what's best for the health of their children.
In Kai's case, she first began questioning her gender identity many years before she told anyone. 'I'd say between the ages of seven and 10, I had these recurring thoughts of, what if I was a girl? What if I wore more feminine clothing?' she told Teen Vogue on a video call. 'It really ramped up the older I got. The older I got, the more frequently I experienced those thoughts.'
Though Kai's family were LGBTQ+ friendly, she attended a religious private school where she says she encountered negative attitudes towards gender and sexuality. These messages led her to push down all thoughts about gender. Hard as she tried, though, these thoughts wouldn't leave her.
In the spring of eighth grade, as her body was changing to become more masculine, Kai found herself actually dreaming of hormone therapy. 'I had this dream where I took estrogen, and I was happy. The changes weren't instant, but they were happening, and I was happier for it,' she remembered. 'And I woke up, and I had to go to work, and I was like, oh shit, I can't run away from this. I'm going to have to confront this head on.'
For their part, Kai's parents say they knew nothing of this inner struggle. Instead, they saw the effects. Kai had meltdowns at school, and in eighth grade she was discovered while she was hurting herself in a school bathroom. She was rushed to the emergency room, and afterwards her parents got her on medication, and a new therapist.
US v. Skrmetti: Trans Teens Like L.W. Just Want to Have a Normal Childhood
*Teen Vogue* reports from the Supreme Court on the morning of a landmark case that could change access to gender-affirming care across the US.
For Kai, getting help needed to start with coming out. After revealing her secret to her new therapist, she worked up the courage to ask her parents to talk, with her therapist's encouragement. Kai and her mother and father gathered in the parents' bedroom.
'I remember just being stunned and in silence for two minutes and then something clicks, like, it's going to have to come out,' Kai explained. 'And I'm like, okay, so basically I'm trans and I've been thinking this for years and da-da-da-da-da.'
In the moment, Kai's parents were stunned, but they did their best to be supportive. After a group hug on their king-sized bed, Esther asked for some time to discuss with Kai's father, saying she'd come by Kai's bedroom to check on her in a few minutes. It was there, in her daughter's bedroom, only a few minutes after learning she had a daughter, that she saw something she had never expected.
'I opened the door, and she was just beaming. She had her headphones in and was just kind of bebopping and like dancing,' Esther said. 'I'd never seen her smile like that. She'd been suffering with depression, [harming] herself, anxiety for years, and just had this heaviness to her. And it was just gone. There was a lightness.'
This moment of revelation is what opened Esther's mind to eventually approving medical options for Kai. She did hours of research, spoke with parents and experts, and had Kai formally assessed. This had to happen outside of their home state, far from the world class gender clinic at St. Louis Children's Hospital, which ceased offering medical options due to Missouri's gender-affirming care ban for minors.
Despite lengthy travel times for out-of-state treatment, the family persevered, eventually finding a clinic in Illinois that evaluated Kai and prescribed medications to increase estrogen and reduce testosterone levels in her body.
Estrogen and testosterone therapy are just two of the treatments that fall under the umbrella of gender-affirming healthcare. Known as sex hormones, healthy human bodies of all sexes make estrogen and testosterone naturally. However, female bodies usually have higher levels of estrogen, and male bodies higher levels of testosterone.
Adjusting those levels to be closer to those of another sex causes changes typical of the puberty of that sex. This includes obvious things like breast growth (with estrogen) or facial hair (with testosterone), but also more subtle changes, for instance to fat distribution, scent, and skin texture.
According to the Trevor Project's 2022 National Survey on LGBTQ Youth Mental Health, most trans youth come out after turning 13. For those who come out even younger, there are other medications, drugs that pause puberty, which are often referred to as 'puberty blockers.' These reversible medications are used to give younger adolescents more time to explore their gender without the potentially harmful effects of going through what feels like the wrong puberty.
'I just absolutely refused to even countenance the idea that there was nothing that could be done for my kid.'
Puberty blockers, which are generally used to address early puberty in children, have been the subject of widespread misinformation, which paint the drugs as experimental and dangerous. Families of trans youth, including very supportive ones, aren't immune to the effects of this propaganda.
Jennifer Harris Dault, who plans to help her 10-year-old trans daughter access puberty blockers once it becomes necessary, absorbed the message that puberty blockers would pose a serious, lifelong change to her child's bone health. In truth, because bone density increases during puberty, puberty blockers pause those changes. The long term effects of the drugs on bone density continue to be studied, however bone density has been found to fully rebound for trans boys and mostly rebound for trans girls after they start hormone therapy.
'I remember just being astounded when the doctor was talking through everything that happens and reporting that [a trans girl's] bone density changes to [be more like] that of a cisgender woman. [Like,] Wait. Isn't… wouldn't [being similar to a cis girl] be the goal?' Harris Dault remembers asking her doctor. 'The more I learned from people whose career was knowing how medications interact with the body, and what their actual purpose is, the less scary things became.'
Although adults (and some teens) also access surgeries to further masculinize or feminize their bodies, it's a myth that medical transition is primarily accomplished through surgery. A KFF/Washington Post survey published in 2023 found that only 16% of trans adults report having had gender-affirming surgery. However, for those with severe gender dysphoria, such procedures can be life-changing.
That's the case for Reese, a 17-year-old trans boy in Texas who had chest masculinization surgery (also known as 'top surgery') as a teenager. Reese is now a thriving junior at a large public high school. But, when he was 10 years old, his family was afraid they might lose him forever.
Reese came out as a boy to his parents at nine, but he'd always been highly masculine, insisting on having a boys' haircut and wearing a boys' uniform at his elementary school. His parents accepted this was how he was and never tried to force him to be feminine but knew nothing about transgender children.
Thinking back, Reese's mom, Melanie, says she knew adult trans people took medical steps, but she hadn't thought it could be an option for a child. 'My kid had been telling me all about all of this sort of thing, you know, talking about top surgery, talking about [testosterone], talking about all these things, and I was like okay buddy, sure,' she explained. 'I just hadn't really taken it seriously. I just thought that's something that, like, we'll cross that bridge when we come to it.'
That changed when her 10 year old confessed to having taken an overdose of over-the-counter medications after getting his period triggered intense gender dysphoria.
During the days that followed, Melanie spent hours at Reese's side in the ER, and met medical professionals who were both trans-affirming and disaffirming. The difference, she says, is that the affirming professionals offered her actual solutions.
'Someone said, look, great news, it's super easy to not have a period. We have nailed the medicine on that. We've got lots of different methods and ways of accomplishing that.'
This hopeful attitude stood in stark contrast with a non-affirming provider, who suggested long-term psychiatric hospitalization.
'The actively transphobic therapist who came through raised the same issue [of Reese's period]. 'Look this is going to be an issue that your kid has to deal with every 30 days, and so basically you just need to accept that your kid is going to need to be institutionalized,'' is how Melanie remembers the conversation going.
She wasn't having it. 'I just absolutely refused to even countenance the idea that there was nothing that could be done for my kid.'
Dear Trans Kids, You Don't Need the Government's Permission to Exist
In youth transition, as in all trans healthcare, individualized treatment is key. The affirming experts Melanie spoke with didn't describe a single, one-size-fits-all transition plan. Instead, they suggested starting small by stopping Reese's periods with well-known birth control methods, starting therapy, and waiting to see how he responded. This slow, careful, individualized process is the opposite of the rushed process anti-trans activists have often described to justify the bans on care at the heart of the Supreme Court case.
After stopping his period and a long stretch of therapy, Reese's family eventually decided testosterone was right for him. Each step seemed to help Reese's mood and adjustment, but his chest continued to be a major source of dysphoria. His mother noticed he was avoiding showering, wearing multiple binders and sleeping with a binder on — even developing skin problems because he never took his binder off.
'I remember that those conversations happened. I remember even saying, 'I need top surgery,'' Reese explained. 'And, my mom was, obviously, like, no. Not because she was unsupportive but because I really was just incredibly young.'
During that time, although he was grateful for his family's support, Reese struggled. 'I was very, very depressed,' he says now. 'I don't even think I was expressly suicidal, if anything, because I didn't want to hurt my family … I didn't want that to happen again, not because I wasn't suicidal or depressed again, but because I almost felt like it would be ungrateful.'
After extensive research and consultation with experts, Reese's parents and doctors decided that the step of chest masculinization surgery, though very rare for a minor, was necessary due to the severity of his dysphoria, which was presenting a clear risk to his medical and emotional health.
Today, Melanie is incredibly glad they finally went forward, but she says the decision to okay surgery for her child was agonizing. She spoke with multiple experts and even read some of the medical literature on chest masculinization. Fears about whether Reese might regret the decision loomed large, but looming even larger, she says, were her concerns that his low quality of life was causing him to miss out on being a teenager.
Now seventeen, Reese is thriving.
'I am doing fantastic. I go to a school that I love, I have a bunch of friends, my grades are fantastic. I'm just doing great,' he told Teen Vogue. 'I'm excited, and I'm figuring out what I want to do after high school and into a post-secondary school, all that. But as for the transness, it's not a big deal anymore. It's not a thing. It's just sort of been addressed.'
These stories represent the reality of many trans youth accessing health care in the U. S. — a reality characterized by careful consideration, individualized care, and remarkable transformations. The Supreme Court is expected to announce whether states can ban families from choosing these treatments in June.
If you're in crisis or experiencing suicidal ideations, help is available. You can reach the suicide and crisis lifeline at 988. To reach an LGBTQ+-trained crisis counselor, dial 988 and press 3. You can also text with an LGBTQ+-trained counselor by sending the word PRIDE to 988, or you can chat online here. You can also reach out to the Trevor Project's crisis services here, by calling 1-866-488-7386, or by texting 'START' to 678678.
Originally Appeared on Teen Vogue
Want to read more Teen Vogue LGBTQ coverage?
12 Things People Get Wrong About Being Nonbinary
How to Have Sex if You're Queer
'What Does LGBTQ Stand For?' Your (Colorful) LGBTQIA+ Glossary
7 Trans People Share What Brings Them Joy

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority
Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority

Newsweek

time26 minutes ago

  • Newsweek

Bernie Sanders Introduces Bill Backing RFK Jr., Elon Musk Priority

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Senator Bernie Sanders is leading a new bill to address a key priority of Robert F. Kennedy Jr., who serves as President Donald Trump's Health and Human Services Secretary. Why It Matters Sanders, a Vermont independent, alongside Senator Angus King, a Maine independent, introduced the "End Prescription Drug Ads Now Act," which, if passed, would ban prescription drug advertising on TV, radio, print and digital platforms as well as social media. Critics say these ads contribute to the high price of healthcare while doing little to improve care in the United States, though proponents say the advertisements can improve patients' knowledge of healthcare. Most wealthy countries, with the U.S. and New Zealand being two notable exceptions, ban pharmaceutical drug advertisements. The bill also represents an issue where Sanders, viewed as perhaps the most progressive senator, has found common ground with Kennedy inside the Trump administration, though the secretary has not commented on this bill specifically. What to Know Sanders and King announced the legislation on Thursday, highlighting that the pharmaceutical industry spent more than $5 billion on TV ads in 2024 and that many of these drugs cost more in the U.S. than in other countries that do not allow drug companies to run ads on TV. "The American people are sick and tired of greedy pharmaceutical companies spending billions of dollars on absurd TV commercials pushing their outrageously expensive prescription drugs," Sanders said, describing the fact that the U.S. stands mostly alone in allowing pharmaceutical ads as an "international embarrassment." vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, D.C. vSenator Bernie Sanders, a Vermont independent, questions U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. during a committee hearing on May 14, 2025 in Washington, director of communications Anna Bahr confirmed to Newsweek his office has reached out to Republicans to join the bill. Bahr pointed to lobbying from the pharmaceutical and health insurance industries as to why the U.S. has not joined other countries in bannign the ads. "Over the past 25 years, the drug companies have spent $8.5 billion on lobbying. Today, they have some 1,800 well-paid lobbyists in Washington, D.C. – including former leaders of the Republican and Democratic parties," she said in a statement to Newsweek. "Unbelievably, that is more than three lobbyists for every member of Congress. During that same period, they have provided over $700 million in campaign contributions. And they are equal opportunity contributors. They contribute heavily to both Republican and Democratic candidates." Secretary Kennedy—as well as Elon Musk, who previously served in Trump's administration—have expressed support for ending pharmaceutical advertising. "Let's get President Trump back in the White House and me to DC so we can ban pharmaceutical advertising," Kennedy wrote in a post to X (formerly Twitter) on November 3, 2024. During his own presidential campaign, Kennedy said he would have issued an executive order ending the advertisements on his first day in office. Newsweek reached out to DHS for comment via the department's press contact form. Caleb Alexander, professor of epidemiology at the Johns Hopkins University Bloomberg School of Public Health, told Newsweek that while a potential ban's impact on drug prices remains uunclear, there would be benefits to ending these advertisements. Pharmaceutical advertisements can drive up "inappropriate demand" for prescription drugs in settings where they may not be needed, he said. "In terms of the potential benefits of banning [direct-to-consumer advertisements], the most immediate and likely is that it would temper demand for products in settings where they may not be needed," Alexander said. The U.S. has "evolved to believe" the benefits of the ads, such as empowering patients to identify health concerns, outweigh the risks, though much of the research on the topic indicates that the benefits may not be worth the drawbacks, he said. What People Are Saying Alexander told Newsweek: "Direct to consumer advertising has been a lightning rod for controversy, and it remains a curious and unique feature of the U.S. marketplace. While a ban on direct advertising may be welcomed by many, it's not going to fundamentally transform the marketplace for prescription drugs in the United States, simply because DTCA is highly concentrated among a small number of products. It may be a reasonable political and public health target, but I think that if you just look at the way the dollars flow, there's vastly more money spent on marketing drugs to prescribers." Senator Angus King wrote in a statement: "The widespread use of direct-to-consumer advertising by pharmaceutical companies drives up costs and doesn't necessarily make patients healthier. The End Prescription Drug Ads Now Act would prohibit direct-to-consumer advertising of pharmaceutical drugs to protect people. This bill is a great step to ensure that patients are getting the best information possible and from the right source: their providers and not biased advertisements." Elon Musk wrote to X in November 2024: "No advertising for pharma." What Happens Next It's unclear whether a majority of senators are also in support of the bill. So far, Democratic Senators Chris Murphy of Connecticut, Peter Welch of Vermont, Jeff Merkley of Oregon and Dick Durbin of Illinois have co-sponsored the bill, according to Sanders' office.

US lawmakers pass tougher penalties for fentanyl traffickers
US lawmakers pass tougher penalties for fentanyl traffickers

Yahoo

time30 minutes ago

  • Yahoo

US lawmakers pass tougher penalties for fentanyl traffickers

The US Congress on Thursday passed a bill imposing harsher penalties on fentanyl traffickers, with lawmakers from both parties anxious to crack down on an opioid that has driven an epidemic of deadly overdoses. The Senate-passed bill -- which delivers on a key election pledge of President Donald Trump to get tough on drug smuggling -- was rubber-stamped by the House on a 321-104 vote, with Democrats providing all but one of the no votes. The Justice Department says 75,000 Americans die each year because of fentanyl, making it the number one cause of death for people between the ages of 18 and 34 in the United States. The synthetic opioid is more potent than heroin and much cheaper to produce. "More Americans die of drug overdoses each year than the number of Americans who died in the entirety of the Vietnam War," Republican Senate Majority Leader John Thune said ahead of the vote. The HALT Fentanyl Act places copycat variations of fentanyl -- often sold by traffickers -- on the government's list of most dangerous "Schedule 1" drugs alongside the original substance. Lab-created fentanyl alternatives were reclassified to "Schedule 1" on a temporary basis seven years ago but the vote makes the change permanent. Trump has made halting the flow of fentanyl one of his priorities, even announcing it as a justification for import tariffs on Mexico and Canada. But opponents said the new law -- rather than tackling overdoses -- would simply repeat the mistakes of the so-called "War on Drugs." The Leadership Conference on Civil and Human Rights, a coalition of more than 240 US rights organizations, said in a statement the measure would "exacerbate pretrial detention, mass incarceration, and racial disparities in the prison system." "Beginning in the 1980s, draconian drug laws with harsh mandatory minimums and their resulting enforcement under the banner of the 'war on drugs' fueled skyrocketing prison populations," it said. ft/acb

US health chief says Sen. Cassidy promised pick on vaccine panel
US health chief says Sen. Cassidy promised pick on vaccine panel

Yahoo

timean hour ago

  • Yahoo

US health chief says Sen. Cassidy promised pick on vaccine panel

WASHINGTON (Reuters) -U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said he told U.S. Senator Bill Cassidy that he would allow Cassidy to pick a candidate for a key panel of vaccine advisers. Cassidy, a Republican, serves as chairman the U.S. Senate Health, Education, Labor, and Pensions Committee. "What I told Senator Cassidy is that I would allow him to put one of his candidates on, which we're going to do," Kennedy said on Thursday during an interview on Fox News' "The Story with Martha MacCallum," referring to the vaccine advisory panel. Kennedy on Wednesday named eight members to serve on the U.S. Centers for Disease Control and Prevention's Advisory Committee for Immunization Practices, which advises the agency on who should get the shots after they are approved by the U.S. Food and Drug Administration, after gutting the panel last week.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store